ArticleBMC bioinformatics2026
Tissueformer: extending single-cell foundation models to predict population-level phenotypes.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
backgroundSingle-cell RNA sequencing technologies have enabled unprecedented insights into gene expression and opened new pathways for diagnostics and tissue annotation. At present, most computational approaches for interpreting single-cell data predict labels or properties based on isolated single-cell transcriptomic profiles. This approach overlooks the cellular composition within a sample, which is often critical for inferring tissue identity or other sample-level phenotypes.
resultsTo address this limitation, we introduce TissueFormer, a Transformer-based neural network that infers population-level labels from groups of single-cell RNA profiles while retaining single-cell resolution. We applied TissueFormer to two tasks: predicting COVID-19 severity from single-cell RNA sequencing of blood samples, and predicting cortical area identity from spatial transcriptomic data in mouse brains. TissueFormer outperformed single-cell foundation models and machine learning methods applied to pseudobulk and cell type composition.
conclusionsTissueFormer's higher performance promises more accurate diagnostics and enables the automated construction of high-resolution brain region maps in individual mice directly from spatial transcriptomic data. Applied to mice with developmental perturbations to visual input, these maps revealed a significant reduction in predicted visual cortex area, illustrating how individual differences in neuroanatomy can be quantified. More broadly, TissueFormer provides a framework for predicting any population-level phenotypes which are influenced by cellular diversity and tissue-level organization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.